Skip to main content
Premium Trial:

Request an Annual Quote

Prolinx Taps VWR to Distribute RapXtract in North America

NEW YORK, Oct. 7 - Prolinx today said it has hired VWR International to distribute its RapXtract superparamagnetic separation technology and accessories in North America.


According to Prolinx, its RapXtract technology, which uses mass action to remove dye labeled precursors from nucleic acid-labeling reactions, allows labs to use minimum sample volumes when performing research such as whole genome analysis, SNP discovery, drug-discovery research, toxicology analysis, and pharmacogenomics.


Prolinx, based in Bothell, Wash., currently sells two product lines based on the technology: RapXtract dye terminator removal kits and RapXtract fluorescent nucleic acid-purification kits.


Click here for more information.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more